UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The Journal of infectious diseases, ISSN 0022-1899, 2/2007, Volume 195, Issue 3, pp. 322 - 329
Relapse | Health care administration | Encephalopathies | Cerebrospinal fluid | Parasites | Dosage | Patient assessment | Trypanosomiasis | African trypanosomiasis | Blood | Trypanosome | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Recurrence | Trypanosomiasis, African - drug therapy | Injections, Intravenous | Drug Administration Schedule | Administration, Oral | Humans | Melarsoprol - administration & dosage | Male | Melarsoprol - therapeutic use | Treatment Outcome | Trypanosoma brucei gambiense | Brain Diseases - chemically induced | Melarsoprol - adverse effects | Animals | Adult | Female | Trypanocidal Agents - therapeutic use | Drug Therapy, Combination | Nifurtimox - therapeutic use | Sleep disorders | Care and treatment | Patient outcomes | Causes of | Research | Trypanosoma brucei | Drug therapy | Index Medicus | Abridged Index Medicus | Parasitology | Nifurtimox | Melarsoprol | Trypanosomiasis, African | Life Sciences | Microbiology and Parasitology | Trypanocidal Agents | Brain Diseases | Santé publique et épidémiologie
Journal Article
Talanta (Oxford), ISSN 0039-9140, 11/2013, Volume 116, pp. 876 - 881
HPLC–ICPMS/ESMS | Melarsoprol | Sleeping sickness | Arsenic | HPLC-ICPMS/ESMS | Melarsoprol Sleeping sickness | Physical Sciences | Chemistry | Chemistry, Analytical | Science & Technology | Trypanocidal Agents - blood | Limit of Detection | Melarsoprol - pharmacology | Serum - metabolism | Drug Stability | Humans | Cells, Cultured | Blood Cells - metabolism | Trypanocidal Agents - chemistry | Blood Proteins - chemistry | Chromatography, High Pressure Liquid | Spectrophotometry, Atomic | Blood Cells - cytology | Spectrometry, Mass, Electrospray Ionization | Trypanocidal Agents - pharmacology | Biotransformation | Arsenicals - chemistry | Melarsoprol - chemistry | Protein Binding | Arsenic - blood | Arsenicals - blood | Blood Cells - drug effects | Melarsoprol - blood | Serum - chemistry | Proteins | Arson | Metabolites | Rain and rainfall | Protein binding | Index Medicus
Journal Article
European journal of pharmaceutics and biopharmaceutics, ISSN 0939-6411, 2008, Volume 70, Issue 2, pp. 649 - 656
Melarsoprol | Cyclodextrin | Nanosuspensions | Arsenic | Leukemia | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Pharmaceutical technology. Pharmaceutical industry | Biological and medical sciences | Medical sciences | General pharmacology | Pharmacology. Drug treatments | 2-Hydroxypropyl-beta-cyclodextrin | Melarsoprol - pharmacology | Humans | Lethal Dose 50 | Trypanocidal Agents - pharmacokinetics | Chemistry, Pharmaceutical | Nanoparticles | Tissue Distribution | Animals | beta-Cyclodextrins - chemistry | Melarsoprol - pharmacokinetics | U937 Cells | K562 Cells | Melarsoprol - chemistry | Female | Antineoplastic Agents - pharmacology | Mice | Suspensions | Index Medicus | Antineoplastic Agents | Life Sciences | beta-Cyclodextrins | Trypanocidal Agents | Pharmaceutical sciences
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2010, Volume 375, Issue 9709, pp. 148 - 159
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | General aspects | Infectious diseases | Parasitic diseases | Protozoal diseases | Biological and medical sciences | Human protozoal diseases | Medical sciences | Trypanosomiasis | Africa - epidemiology | Insect Vectors | Tsetse Flies - parasitology | Humans | Pentamidine - therapeutic use | Trypanosoma brucei gambiense - pathogenicity | Trypanosoma brucei gambiense - immunology | Melarsoprol - therapeutic use | Insect Bites and Stings - prevention & control | Eflornithine - therapeutic use | Communicable Disease Control - methods | Incidence | Variant Surface Glycoproteins, Trypanosoma - immunology | Trypanosomiasis, African - transmission | Animals | Trypanosomiasis, African - diagnosis | Suramin - therapeutic use | Trypanosomiasis, African - epidemiology | Biomedical Research | Trypanocidal Agents - therapeutic use | Endemic Diseases - prevention & control | Trypanosomiasis, African - therapy | Drugs | Insects | Medical diagnosis | Rural areas | Health services | Tropical diseases | Index Medicus | Abridged Index Medicus
Journal Article
Tropical medicine & international health, ISSN 1360-2276, 11/2001, Volume 6, Issue 11, pp. 906 - 914
treatment | drug resistance | relapse | Trypanosoma brucei gambiense | Trypanosoma brucei rhodesiense | melarsoprol | Melarsoprol | Relapse | Treatment | Drug resistance | Biological and medical sciences | Antiparasitic agents | Tropical medicine | Medical sciences | Pharmacology. Drug treatments | Antibiotics. Antiinfectious agents. Antiparasitic agents | Recurrence | Trypanocidal Agents - blood | Trypanosomiasis, African - drug therapy | Parasitic Sensitivity Tests | Humans | Melarsoprol - therapeutic use | Dose-Response Relationship, Drug | Trypanosoma brucei gambiense - drug effects | Treatment Failure | Trypanosomiasis, African - epidemiology | Trypanocidal Agents - cerebrospinal fluid | Trypanocidal Agents - therapeutic use | Trypanosoma brucei gambiense - isolation & purification | Africa, Eastern - epidemiology | Drug Resistance | Melarsoprol - cerebrospinal fluid | Trypanosoma brucei rhodesiense - isolation & purification | Trypanocidal Agents - pharmacokinetics | Trypanosomiasis, African - parasitology | Animals | Melarsoprol - pharmacokinetics | Muridae | Mice | Trypanosoma brucei rhodesiense - drug effects | Melarsoprol - blood | Index Medicus
Journal Article
International journal of pharmaceutics, ISSN 0378-5173, 2005, Volume 306, Issue 1, pp. 107 - 121
Melarsoprol | Complexation | Cytotoxicity | Hydroxypropyl-β-cyclodextrin | Nuclear magnetic resonance | Methylated-β-cyclodextrin | Hydroxypropyl-β- cyclodextrin | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Pharmaceutical technology. Pharmaceutical industry | Biological and medical sciences | Medical sciences | General pharmacology | Pharmacology. Drug treatments | Cell Survival - drug effects | Magnetic Resonance Spectroscopy | Melarsoprol - pharmacology | Drug Stability | Humans | Solubility | Antineoplastic Agents - chemistry | Cyclodextrins - chemistry | Cell Line, Tumor | Drug Compounding | Melarsoprol - chemistry | Antineoplastic Agents - pharmacology | Molecular Structure | Kinetics | Cyclodextrins - pharmacology | Hydrolysis | Antiparasitic agents | Cyclodextrins | Analysis | Leukemia | Index Medicus | Cell Survival | Antineoplastic Agents | Life Sciences | Pharmaceutical sciences
Journal Article
The Lancet infectious diseases, ISSN 1473-3099, 2002, Volume 2, Issue 7, pp. 437 - 440
Life Sciences & Biomedicine | Infectious Diseases | Science & Technology | Trypanosomiasis, African - drug therapy | Trypanocidal Agents - adverse effects | Nifurtimox - administration & dosage | Humans | Trypanosoma brucei rhodesiense | Africa South of the Sahara | Melarsoprol - administration & dosage | Eflornithine - adverse effects | Melarsoprol - therapeutic use | Eflornithine - therapeutic use | Trypanosoma brucei gambiense | Melarsoprol - adverse effects | Animals | Nifurtimox - adverse effects | Thiadiazoles - therapeutic use | Benzamidines - therapeutic use | Trypanocidal Agents - therapeutic use | Drug Therapy, Combination | Eflornithine - administration & dosage | Nifurtimox - therapeutic use | Trypanocidal Agents - administration & dosage | Index Medicus
Journal Article
Molecular and biochemical parasitology, ISSN 0166-6851, 2011, Volume 175, Issue 1, pp. 91 - 94
Melarsoprol | Amino acid | Trypanosoma brucei | Drug resistance | Transporter | Eflornithine | Biochemistry & Molecular Biology | Parasitology | Life Sciences & Biomedicine | Science & Technology | Melarsoprol - pharmacology | Trypanosoma brucei brucei - metabolism | Gene Silencing | Eflornithine - pharmacology | Trypanosoma brucei brucei - genetics | Protozoan Proteins - genetics | Antiprotozoal Agents - pharmacology | Gene Knockdown Techniques - methods | Trypanosoma brucei brucei - drug effects | Protozoan Proteins - metabolism | Transfection - methods | Membrane Transport Proteins - genetics | Membrane Transport Proteins - metabolism | Blood - parasitology | Antiparasitic agents | Amino acids | RNA | Genomics | Index Medicus | Adenosine
Journal Article
Emerging infectious diseases, ISSN 1080-6040, 2008, Volume 14, Issue 6, pp. 966 - 967
Journal Article
Emerging infectious diseases, ISSN 1080-6040, 06/2008, Volume 14, Issue 6, pp. 966 - 967
Infectious Diseases | Immunology | Life Sciences & Biomedicine | Science & Technology | Recurrence | Trypanosomiasis, African - drug therapy | Humans | Middle Aged | Child, Preschool | Melarsoprol - administration & dosage | Trypanosomiasis, African - prevention & control | Infant | Male | Melarsoprol - therapeutic use | Trypanosomiasis, African - parasitology | Democratic Republic of the Congo - epidemiology | Animals | Treatment Failure | Adolescent | Adult | Female | Trypanocidal Agents - therapeutic use | Child | Trypanocidal Agents - administration & dosage | treatment | Dispatch | Human African trypanosomiasis | relapse | melarsoprol
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 9/2005, Volume 41, Issue 5, pp. 748 - 751
Brief Reports | Infectious diseases | Intravenous injections | Mortality | Diarrhea | Encephalopathies | Adverse effects | Dosage | African trypanosomiasis | Lymph nodes | Diseases | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Trypanosomiasis, African - drug therapy | Trypanocidal Agents - adverse effects | Humans | Eflornithine - adverse effects | Male | Melarsoprol - therapeutic use | Eflornithine - therapeutic use | Sudan - epidemiology | Melarsoprol - adverse effects | Trypanosomiasis, African - mortality | Adolescent | Adult | Female | Trypanocidal Agents - therapeutic use | Child | Dosage and administration | Drug therapy | Trypanosoma brucei | Eflornithine | Drugs | Health risk assessment | Comparative analysis | Medical treatment | Index Medicus
Journal Article
Cellular and molecular life sciences : CMLS, ISSN 1420-682X, 09/2016, Volume 73, Issue 17, pp. 3387 - 3400
African trypanosomes | Melarsoprol | RNA-binding protein | Pentamidine | Purine permease | Aquaporin | Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Science & Technology | Cell Biology | RNA-Binding Proteins - genetics | Parasitic Sensitivity Tests | Genome, Protozoan | Humans | Male | Nucleoside Transport Proteins - metabolism | Protozoan Proteins - genetics | Aquaporins - genetics | Protozoan Proteins - metabolism | Trypanosomiasis, African - diagnosis | Trypanosoma brucei rhodesiense - genetics | DNA, Protozoan - chemistry | Pentamidine - pharmacology | Amino Acid Sequence | DNA, Protozoan - isolation & purification | Melarsoprol - pharmacology | Nucleoside Transport Proteins - genetics | Aquaporins - metabolism | Trypanosoma brucei rhodesiense - isolation & purification | Drug Resistance - genetics | Trypanosomiasis, African - parasitology | Phenotype | Sequence Alignment | Comparative Genomic Hybridization | Trypanocidal Agents - pharmacology | DNA, Protozoan - metabolism | Heterozygote | Polymorphism, Single Nucleotide | Trypanosoma brucei rhodesiense - drug effects | RNA-Binding Proteins - metabolism | Evolutionary biology | RNA | Gene mutations | Aquaporins | Genomics | Genetic research | Drug resistance | Comparative analysis | Protein binding | Comparative studies | Parasitic protozoa | Pharmacology | Parasitic diseases | Index Medicus | Original
Journal Article